MeasurableQuantitativeAnnotation  

PubMed:32224151 JSONTXT 12 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
N1 850-852 num denotes 28
E1 853-886 entity denotes COVID-19-infected cancer patients
N1 902-904 num denotes 17
N2 906-910 num denotes 60.7
U1 910-911 unit denotes %
E1 927-931 entity denotes male
E1 933-943 entity denotes Median age
N1 948-952 num denotes 65.0
U1 953-958 unit denotes years
E1 1171-1176 entity denotes fever
N1 1178-1180 num denotes 23
N2 1182-1186 num denotes 82.1
U1 1186-1187 unit denotes %
E2 1190-1199 entity denotes dry cough
N3 1201-1203 num denotes 22
N4 1205-1207 num denotes 81
U2 1207-1208 unit denotes %
E3 1214-1222 entity denotes dyspnoea
N5 1224-1226 num denotes 14
N6 1228-1232 num denotes 50.0
U3 1232-1233 unit denotes %
E4 1247-1259 entity denotes lymphopaenia
N7 1261-1263 num denotes 23
N8 1265-1269 num denotes 82.1
U4 1269-1270 unit denotes %
E7 1287-1322 entity denotes high-sensitivity C-reactive protein
N13 1324-1326 num denotes 23
N14 1328-1332 num denotes 82.1
U7 1332-1333 unit denotes %
E5 1336-1343 entity denotes anaemia
N9 1345-1347 num denotes 21
N10 1349-1353 num denotes 75.0
U5 1353-1354 unit denotes %
E6 1360-1376 entity denotes hypoproteinaemia
N11 1378-1380 num denotes 25
N12 1382-1386 num denotes 89.3
U6 1386-1387 unit denotes %
E1 1424-1444 entity denotes ground-glass opacity
N1 1446-1448 num denotes 21
N2 1450-1454 num denotes 75.0
U1 1454-1455 unit denotes %
E2 1461-1481 entity denotes patchy consolidation
N3 1483-1485 num denotes 13
N4 1487-1491 num denotes 46.3
U2 1491-1492 unit denotes %
N1 1495-1497 num denotes 15
N2 1499-1503 num denotes 53.6
U1 1503-1504 unit denotes %
E1 1519-1532 entity denotes severe events
E2 1537-1546 entity denotes mortality
N3 1551-1555 num denotes 28.6
U2 1555-1556 unit denotes %
R1 E1 N1 associateWith severe events,15
R1 E1 N1 associateWith severe events,15
R1 E1 N1 associateWith severe events,15
R1 E1 N1 associateWith severe events,15
R1 E1 N1 associateWith severe events,15
R1 E1 N1 associateWith severe events,15
R10 E4 N7 associateWith lymphopaenia,23
R11 E4 N8 associateWith lymphopaenia,82.1
R12 N8 U4 associateOf 82.1,%
R13 E5 N9 associateWith anaemia,21
R14 E5 N10 associateWith anaemia,75.0
R15 N10 U5 associateOf 75.0,%
R16 E6 N11 associateWith hypoproteinaemia,25
R17 E6 N12 associateWith hypoproteinaemia,89.3
R18 N12 U6 associateOf 89.3,%
R19 E7 N13 associateWith high-sensitivity C-reactive protein,23
R2 E1 N2 associateWith severe events,53.6
R2 N1 U1 associateOf 15,%
R2 E1 N2 associateWith severe events,53.6
R2 E1 N2 associateWith severe events,53.6
R2 E1 N2 associateWith severe events,53.6
R20 E7 N14 associateWith high-sensitivity C-reactive protein,82.1
R21 N14 U7 associateOf 82.1,%
R3 N2 U1 associateOf 53.6,%
R3 N2 U1 associateOf 53.6,%
R3 N2 U1 associateOf 53.6,%
R3 N2 U1 associateOf 53.6,%
R4 E2 N3 associateWith mortality,28.6
R4 E2 N3 associateWith mortality,28.6
R4 E2 N3 associateWith mortality,28.6
R5 E2 N4 associateWith mortality,46.3
R5 E2 N4 associateWith mortality,46.3
R5 N3 U2 associateOf 28.6,%
R6 N4 U2 associateOf 46.3,%
R6 N4 U2 associateOf 46.3,%
R7 E3 N5 associateWith dyspnoea,14
R8 E3 N6 associateWith dyspnoea,50.0
R9 N6 U3 associateOf 50.0,%